ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Missouri » Geriatric Medicine

Top Geriatric Medicine Prescribers in Missouri

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DEATRICE KELLOGG MD

Geriatric Medicine

27,690

$1.7M

732
639 are 65+

8%
patients receiving schedule two controlled substances

Avg: 8%

20%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$61
Average prescription price

Avg: $61

JON DEDON M.D.

Geriatric Medicine

13,178

$918K

183
132 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 24%

$70
Average prescription price

Avg: $61

MOHAMMED MOJID M.D.

Geriatric Medicine

17,755

$1.1M

518
342 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

23%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $61

RAJAMANICKAM PURUSHOTHAMAN MD

Geriatric Medicine

14,089

$813K

455
401 are 65+

12%
patients receiving schedule two controlled substances

Avg: 8%

15%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$58
Average prescription price

Avg: $61

GRANT BARNUM D.O.

Geriatric Medicine

16,728

$925K

820
694 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

20%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $61

PETER HOLT MD

Geriatric Medicine

18,894

$1.09M

859
832 are 65+

5%
patients receiving schedule two controlled substances

Avg: 8%

12%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$58
Average prescription price

Avg: $61

RIFFAT IMDAD M.D.

Geriatric Medicine

14,248

$771K

356
341 are 65+

14%
patients receiving schedule two controlled substances

Avg: 8%

18%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $61

FREDERICK YAP M.D.

Geriatric Medicine

2,001

$99.2K

127
111 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

9%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $61

JOHN MORLEY MD

Geriatric Medicine

12,908

$778K

396
339 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

17%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$60
Average prescription price

Avg: $61

GOPAL NAIR MD

Geriatric Medicine

20,207

$950K

321
262 are 65+

22%
patients receiving schedule two controlled substances

Avg: 8%

33%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$47
Average prescription price

Avg: $61

KEVIN FARRELL D.O.

Geriatric Medicine

17,039

$925K

395
326 are 65+

13%
patients receiving schedule two controlled substances

Avg: 8%

21%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $61

MARY BUSS MD

Geriatric Medicine

5,376

$261K

378
318 are 65+

9%
patients receiving schedule two controlled substances

Avg: 8%

15%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $61

ANNE EGBERT M.D.

Geriatric Medicine

1,335

$74.8K

200
189 are 65+

6%
patients receiving schedule two controlled substances

Avg: 8%

20%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$56
Average prescription price

Avg: $61

BRENT BEASLEY MD

Geriatric Medicine

1,274

$58.9K

67
55 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$46
Average prescription price

Avg: $61

SYED TARIQ MD

Geriatric Medicine

552

$24.8K

235
154 are 65+

19%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 24%

$45
Average prescription price

Avg: $61

SHELLEY ALEXANDER D.O.

Geriatric Medicine

5,381

$399K

161
56 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

13%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$74
Average prescription price

Avg: $61

ROSHAN SABAR M.D.

Geriatric Medicine

18,627

$919K

374
342 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

17%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $61

STEPHEN SUGARBAKER M.D.

Geriatric Medicine

540

$24.6K

90
55 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$46
Average prescription price

Avg: $61

DAVID THOMAS MD

Geriatric Medicine

4,181

$212K

118
105 are 65+

25%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $61

YELENA MELYAKOVA M.D.

Geriatric Medicine

1,873

$125K

224
220 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 24%

$67
Average prescription price

Avg: $61

DULCE CRUZ OLIVER MD

Geriatric Medicine

3,358

$195K

136
121 are 65+

13%
patients receiving schedule two controlled substances

Avg: 8%

12%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$58
Average prescription price

Avg: $61

UCHENNA OGBUOKIRI MD

Geriatric Medicine

1,874

$83.9K

117
53 are 65+

14%
patients receiving schedule two controlled substances

Avg: 8%

15%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$45
Average prescription price

Avg: $61

CYNTHIA GILL D.O.

Geriatric Medicine

1,390

$71.3K

67
50 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $61

ELLEN BINDER MD

Geriatric Medicine

2,280

$156K

82
82 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 24%

$69
Average prescription price

Avg: $61

KATHLEEN SPROULES D.O.

Geriatric Medicine

3,376

$201K

103
94 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

13%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$59
Average prescription price

Avg: $61

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank